MICROCHIP TECHNOLOGY INCORPORATED AND SUBSIDIARIES | |||||||||||||||
RECONCILIATION OF GAAP TO NON-GAAP MEASURES | |||||||||||||||
(in thousands except per share amounts and percentages) | |||||||||||||||
(Unaudited) | |||||||||||||||
| |||||||||||||||
RECONCILIATION OF GAAP NET SALES TO NON-GAAP NET SALES | |||||||||||||||
|
Three months ended |
|
Nine months ended | ||||||||||||
|
December 31, |
|
December 31, | ||||||||||||
|
2015 |
|
2014 |
|
2015 |
|
2014 | ||||||||
Net sales, as reported |
$ |
540,344 |
|
|
$ |
528,710 |
|
|
$ |
1,615,687 |
|
|
$ |
1,603,829 |
|
Distributor revenue recognition adjustment |
11,669 |
|
|
7,118 |
|
|
29,710 |
|
|
9,587 |
| ||||
Non-GAAP net sales |
$ |
552,013 |
|
|
$ |
535,828 |
|
|
$ |
1,645,397 |
|
|
$ |
1,613,416 |
|
| |||||||||||||||
RECONCILIATION OF GAAP GROSS PROFIT TO NON-GAAP GROSS PROFIT | |||||||||||||||
|
Three months ended |
|
Nine months ended | ||||||||||||
|
December 31, |
|
December 31, | ||||||||||||
|
2015 |
|
2014 |
|
2015 |
|
2014 | ||||||||
Gross profit, as reported |
$ |
292,718 |
|
|
$ |
301,959 |
|
|
$ |
902,685 |
|
|
$ |
915,932 |
|
Distributor revenue recognition adjustment, net of product cost |
6,936 |
|
|
3,203 |
|
|
18,399 |
|
|
4,565 |
| ||||
Share-based compensation expense |
2,270 |
|
|
2,290 |
|
|
6,325 |
|
|
6,985 |
| ||||
Acquisition-related restructuring and acquired inventory valuation costs |
17,817 |
|
|
4,191 |
|
|
27,449 |
|
|
24,692 |
| ||||
Non-GAAP gross profit |
$ |
319,741 |
|
|
$ |
311,643 |
|
|
$ |
954,858 |
|
|
$ |
952,174 |
|
Non-GAAP gross profit percentage |
57.9 |
% |
|
58.2 |
% |
|
58.0 |
% |
|
59.0 |
% | ||||
| |||||||||||||||
RECONCILIATION OF GAAP RESEARCH AND DEVELOPMENT EXPENSES TO NON-GAAP RESEARCH AND DEVELOPMENT EXPENSES | |||||||||||||||
|
Three months ended |
|
Nine months ended | ||||||||||||
|
December 31, |
|
December 31, | ||||||||||||
|
2015 |
|
2014 |
|
2015 |
|
2014 | ||||||||
Research and development expenses, as reported |
$ |
97,022 |
|
|
$ |
88,697 |
|
|
$ |
276,958 |
|
|
$ |
261,881 |
|
Share-based compensation expense |
(7,855) |
|
|
(7,075) |
|
|
(23,623) |
|
|
(20,645) |
| ||||
Non-GAAP research and development expenses |
$ |
89,167 |
|
|
$ |
81,622 |
|
|
$ |
253,335 |
|
|
$ |
241,236 |
|
Non-GAAP research and development expenses as a percentage of net sales |
16.2 |
% |
|
15.2 |
% |
|
15.4 |
% |
|
15.0 |
% | ||||
| |||||||||||||||
RECONCILIATION OF GAAP SELLING, GENERAL AND ADMINISTRATIVE EXPENSES TO NON-GAAP SELLING, GENERAL AND ADMINISTRATIVE EXPENSES | |||||||||||||||
|
Three months ended |
|
Nine months ended | ||||||||||||
|
December 31, |
|
December 31, | ||||||||||||
|
2015 |
|
2014 |
|
2015 |
|
2014 | ||||||||
Selling, general and administrative expenses, as reported |
$ |
76,270 |
|
|
$ |
66,668 |
|
|
$ |
223,377 |
|
|
$ |
207,037 |
|
Share-based compensation expense |
(6,840) |
|
|
(5,454) |
|
|
(24,155) |
|
|
(15,783) |
| ||||
Acquisition-related costs |
(1,461) |
|
|
(523) |
|
|
(4,698) |
|
|
(3,260) |
| ||||
Non-GAAP selling, general and administrative expenses |
$ |
67,969 |
|
|
$ |
60,691 |
|
|
$ |
194,524 |
|
|
$ |
187,994 |
|
Non-GAAP selling, general and administrative expenses as a percentage of net sales |
12.3 |
% |
|
11.3 |
% |
|
11.8 |
% |
|
11.7 |
% | ||||
| |||||||||||||||
RECONCILIATION OF GAAP OPERATING EXPENSES TO NON-GAAP OPERATING EXPENSES | |||||||||||||||
|
Three months ended |
|
Nine months ended | ||||||||||||
|
December 31, |
|
December 31, | ||||||||||||
|
2015 |
|
2014 |
|
2015 |
|
2014 | ||||||||
Operating expenses, as reported |
$ |
216,586 |
|
|
$ |
203,950 |
|
|
$ |
630,286 |
|
|
$ |
600,659 |
|
Share-based compensation expense |
(14,695) |
|
|
(12,529) |
|
|
(47,778) |
|
|
(36,428) |
| ||||
Acquisition-related costs |
(1,461) |
|
|
(523) |
|
|
(4,698) |
|
|
(3,260) |
| ||||
Amortization of acquired intangible assets |
(48,312) |
|
|
(47,582) |
|
|
(126,764) |
|
|
(129,659) |
| ||||
Special income (charges), net |
5,018 |
|
|
(1,003) |
|
|
(3,187) |
|
|
(2,082) |
| ||||
Non-GAAP operating expenses |
$ |
157,136 |
|
|
$ |
142,313 |
|
|
$ |
447,859 |
|
|
$ |
429,230 |
|
Non-GAAP operating expenses as a percentage of net sales |
28.5 |
% |
|
26.6 |
% |
|
27.2 |
% |
|
26.6 |
% | ||||
| |||||||||||||||
RECONCILIATION OF GAAP OPERATING INCOME TO NON-GAAP OPERATING INCOME | |||||||||||||||
|
Three months ended |
|
Nine months ended | ||||||||||||
|
December 31, |
|
December 31, | ||||||||||||
|
2015 |
|
2014 |
|
2015 |
|
2014 | ||||||||
Operating income, as reported |
$ |
76,132 |
|
|
$ |
98,009 |
|
|
$ |
272,399 |
|
|
$ |
315,273 |
|
Distributor revenue recognition adjustment |
6,936 |
|
|
3,203 |
|
|
18,399 |
|
|
4,565 |
| ||||
Share-based compensation expense |
16,965 |
|
|
14,819 |
|
|
54,103 |
|
|
43,413 |
| ||||
Acquisition-related restructuring, acquired inventory valuation and other costs |
19,278 |
|
|
4,714 |
|
|
32,147 |
|
|
27,952 |
| ||||
Amortization of acquired intangible assets |
48,312 |
|
|
47,582 |
|
|
126,764 |
|
|
129,659 |
| ||||
Special (income) charges, net |
(5,018) |
|
|
1,003 |
|
|
3,187 |
|
|
2,082 |
| ||||
Non-GAAP operating income |
$ |
162,605 |
|
|
$ |
169,330 |
|
|
$ |
506,999 |
|
|
$ |
522,944 |
|
Non-GAAP operating income as a percentage of net sales |
29.5 |
% |
|
31.6 |
% |
|
30.8 |
% |
|
32.4 |
% | ||||
| |||||||||||||||
RECONCILIATION OF GAAP OTHER EXPENSE, NET TO NON-GAAP OTHER EXPENSE, NET | |||||||||||||||
|
Three months ended |
|
Nine months ended | ||||||||||||
|
December 31, |
|
December 31, | ||||||||||||
|
2015 |
|
2014 |
|
2015 |
|
2014 | ||||||||
Other expense, net, as reported |
$ |
(25,918) |
|
|
$ |
(11,756) |
|
|
$ |
(48,430) |
|
|
$ |
(31,258) |
|
Gain on equity securities and equity method investment |
(83) |
|
|
— |
|
|
(16,147) |
|
|
— |
| ||||
Non-cash other expense, net |
12,813 |
|
|
2,501 |
|
|
37,085 |
|
|
7,311 |
| ||||
Impairment on available-for-sale investment |
3,995 |
|
|
— |
|
|
3,995 |
|
|
— |
| ||||
Other expenses on acquisition restructuring |
501 |
|
|
— |
|
|
501 |
|
|
— |
| ||||
Non-GAAP other expense, net |
$ |
(8,692) |
|
|
$ |
(9,255) |
|
|
$ |
(22,996) |
|
|
$ |
(23,947) |
|
Non-GAAP other expense, net, as a percentage of net sales |
(1.6) |
% |
|
(1.7) |
% |
|
(1.4) |
% |
|
(1.5) |
% | ||||
| |||||||||||||||
RECONCILIATION OF GAAP INCOME TAX (BENEFIT) PROVISION TO NON-GAAP INCOME TAX PROVISION | |||||||||||||||
|
Three months ended |
|
Nine months ended | ||||||||||||
|
December 31, |
|
December 31, | ||||||||||||
|
2015 |
|
2014 |
|
2015 |
|
2014 | ||||||||
Income tax (benefit) provision, as reported |
$ |
(11,053) |
|
|
$ |
1,393 |
|
|
$ |
(32,890) |
|
|
$ |
17,141 |
|
Income tax rate, as reported |
(22.0) |
% |
|
1.6 |
% |
|
(14.7) |
% |
|
6.0 |
% | ||||
Distributor revenue recognition adjustment |
2,556 |
|
|
448 |
|
|
6,810 |
|
|
823 |
| ||||
Share-based compensation expense |
5,460 |
|
|
3,632 |
|
|
17,566 |
|
|
6,885 |
| ||||
Acquisition-related restructuring, acquired inventory valuation costs, intangible asset amortization and other costs |
12,797 |
|
|
5,799 |
|
|
32,781 |
|
|
14,696 |
| ||||
Special (income) charges, net |
(201) |
|
|
339 |
|
|
1,414 |
|
|
723 |
| ||||
Non-cash other expense, net |
4,722 |
|
|
929 |
|
|
13,734 |
|
|
2,716 |
| ||||
Gain on equity securities and equity method investment |
(31) |
|
|
— |
|
|
(31) |
|
|
— |
| ||||
Impairment on available-for-sale investment |
1,472 |
|
|
— |
|
|
1,472 |
|
|
— |
| ||||
Non-recurring tax events |
(301) |
|
|
3,931 |
|
|
12,406 |
|
|
9,983 |
| ||||
Non-GAAP income tax provision |
$ |
15,421 |
|
|
$ |
16,471 |
|
|
$ |
53,262 |
|
|
$ |
52,967 |
|
Non-GAAP income tax rate |
10.0 |
% |
|
10.3 |
% |
|
11.0 |
% |
|
10.6 |
% | ||||
| |||||||||||||||
RECONCILIATION OF GAAP NET INCOME ATTRIBUTABLE TO MICROCHIP TECHNOLOGY AND GAAP DILUTED NET INCOME PER COMMON SHARE ATTRIBUTABLE TO MICROCHIP TECHNOLOGY STOCKHOLDERS TO NON-GAAP NET INCOME ATTRIBUTABLE TO MICROCHIP TECHNOLOGY AND NON-GAAP DILUTED NET INCOME PER COMMON SHARE ATTRIBUTABLE TO MICROCHIP TECHNOLOGY STOCKHOLDERS | |||||||||||||||
|
Three months ended |
|
Nine months ended | ||||||||||||
|
December 31, |
|
December 31, | ||||||||||||
|
2015 |
|
2014 |
|
2015 |
|
2014 | ||||||||
Net income attributable to Microchip Technology, as reported |
$ |
61,211 |
|
|
$ |
86,057 |
|
|
$ |
256,777 |
|
|
$ |
269,607 |
|
Noncontrolling interests |
— |
|
|
(1,533) |
|
|
(375) |
|
|
(3,623) |
| ||||
Distributor revenue recognition adjustment, net of tax effect |
4,380 |
|
|
2,755 |
|
|
11,589 |
|
|
3,742 |
| ||||
Share-based compensation expense, net of tax effect |
11,505 |
|
|
11,187 |
|
|
36,537 |
|
|
36,528 |
| ||||
Acquisition-related restructuring, acquired inventory valuation costs, intangible asset amortization and other costs, net of tax effect |
55,294 |
|
|
46,497 |
|
|
126,631 |
|
|
142,915 |
| ||||
Special (income) charges, net of tax effect |
(4,817) |
|
|
664 |
|
|
1,773 |
|
|
1,359 |
| ||||
Gain on equity securities and equity method investment, net of tax effect |
(52) |
|
|
— |
|
|
(16,116) |
|
|
— |
| ||||
Non-cash other expense, net of tax effect |
8,091 |
|
|
1,572 |
|
|
23,351 |
|
|
4,595 |
| ||||
Impairment on available-for-sale investment, net of tax effect |
2,523 |
|
|
— |
|
|
2,523 |
|
|
— |
| ||||
Non-recurring tax events |
301 |
|
|
(3,931) |
|
|
(12,406) |
|
|
(9,983) |
| ||||
Non-GAAP net income attributable to Microchip Technology |
$ |
138,436 |
|
|
$ |
143,268 |
|
|
$ |
430,284 |
|
|
$ |
445,140 |
|
Non-GAAP net income attributable to Microchip Technology as a percentage of net sales |
25.1 |
% |
|
26.7 |
% |
|
26.2 |
% |
|
27.6 |
% | ||||
|
|
|
|
|
|
|
| ||||||||
Diluted net income per common share attributable to Microchip Technology stockholders, as reported |
$ |
0.28 |
|
|
$ |
0.39 |
|
|
$ |
1.18 |
|
|
$ |
1.20 |
|
Non-GAAP diluted net income per common share attributable to Microchip Technology stockholders |
$ |
0.64 |
|
|
$ |
0.64 |
|
|
$ |
1.98 |
|
|
$ |
1.99 |
|
Diluted common shares outstanding, as reported |
217,975 |
|
|
223,487 |
|
|
217,280 |
|
|
224,433 |
| ||||
Diluted common shares outstanding Non-GAAP |
217,975 |
|
|
223,077 |
|
|
217,109 |
|
|
223,883 |
|